INGALLS & SNYDER LLC - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is and the CUSIP is 00430HAB8. A total of 15 filers reported holding ACCELERATE DIAGNOSTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
INGALLS & SNYDER LLC ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q4 2022$710
-99.9%
769,0000.0%0.04%0.0%
Q3 2022$699,000
+37.3%
769,0000.0%0.04%
+44.4%
Q2 2022$509,000
-10.5%
769,000
-4.9%
0.03%
+8.0%
Q1 2022$569,000
-7.0%
809,0000.0%0.02%
-10.7%
Q4 2021$612,000
+15.0%
809,000
-0.7%
0.03%
+16.7%
Q3 2021$532,000815,0000.02%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 9,860,000$7,747,0002.42%
Cowen Prime Services LLC 6,050,000$3,280,0002.00%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 12,000,000$6,505,0000.17%
ANGELO GORDON & CO., L.P. 4,000,000$2,168,0000.16%
LINDEN ADVISORS LP 14,500,000$8,023,0000.14%
Graham Capital Management, L.P. 2,500,000$1,385,0000.10%
WESTWOOD HOLDINGS GROUP INC 9,030,000$4,948,0000.08%
BlueCrest Capital Management Ltd 1,500,000$820,0000.06%
WOLVERINE ASSET MANAGEMENT LLC 4,000,000$2,193,0000.03%
CAPSTONE INVESTMENT ADVISORS, LLC 3,250,000$1,811,0000.03%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders